Remote Strategic Account Lead – Rare Neurology (ALS)

Otsuka America Pharmaceutical Inc.; Boston (MA); À distance; USD 158 000 - 252 000; Plein temps

Résumé du poste

Otsuka America Pharmaceutical Inc. seeks a Strategic Account Liaison to launch and grow FUS-ALS in the Rare Neurology franchise. You will communicate complex clinical data, screening pathways, and access information to ALS Centers of Excellence and health care providers, driving patient care and program adoption.

The role is field-based, remote, full-time, with a focus on market access, patient support, and cross-functional collaboration to advance Otsuka’s rare neurology goals.

Qualifications

• Experience in understanding complex disease states and ability to articulate complex clinical data.
• Educate on disease state awareness, screening and diagnostic pathways, and treatment urgency.
• Develop and maintain relationships with HCPs and KOLs with clinical credibility.
• Explain access and patient support programs to facilitate prescribing.
• Present at conferences and scientific meetings to educate on rare neurology therapies.

Responsabilités

• Communicate complex clinical data, protocols, screening and treatment pathways to ALS Centers of Excellence and key stakeholders.
• Drive regional strategy by synthesizing data, feedback, and market intelligence.
• Navigate site-of-care, patient onboarding, and therapy initiation barriers.
• Articulate access specifics and partner with Market Access and Patient Support to remove barriers.

Connaissances

Clinical acumen

HCP engagement

Strategic thinking

Communication

Region residency

Formation

Bachelor's Degree

Description du poste

Otsuka America Pharmaceutical Inc. seeks a Strategic Account Liaison to launch and grow FUS-ALS in the Rare Neurology franchise. You will communicate complex clinical data, screening pathways, and access information to ALS Centers of Excellence and health care providers, driving patient care and program adoption.

The role is field-based, remote, full-time, with a focus on market access, patient support, and cross-functional collaboration to advance Otsuka’s rare neurology goals.